Document is current
Any future updates will be listed below
-
Authors
Tian, Yonggui
Wen, Chunli
Zhang, Zhen
Liu, Yanfen
Li, Feng
Zhao, Qitai
Yao, Chang
Ni, Kaiyuan
Yang, Shengli
Zhang, Yi https://orcid.org/0000-0001-9861-4681
-
Funding
Funding for this research was provided by:
the National Natural Science Foundation of China (81771781)
National Science and Technology Major Project of China (2020ZX09201-009)
Program of the Major Research Plan of the National Natural Science Foundation of China (91942314)
Major public welfare projects in Henan Province (201300310400)
National Natural Science Foundation of China General Program (81872333)
- License Information
-
More Information
Article History
Received: 9 December 2021
Accepted: 14 March 2022
First Online: 29 March 2022
Declarations
:
: The authors declare no conflict of interest.
: All authors agree with submission to Cancer Immunology, Immunotherapy.
: Our study was reviewed and approved by the Ethics Committee of First Hospital of Zhengzhou University.
: All animal experiments were approved by the Animal Care and Ethics Committee of the First Affiliated Hospital of Zhengzhou University.
: Informed consent was obtained from all participants included in the study.
